Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
Nemaura Medical Employees
Nemaura Medical had 36 employees as of March 31, 2023. The number of employees increased by 4 or 12.50% compared to the previous year.
Employees
36
Change (1Y)
4
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$295,859
Market Cap
4.04K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Nemaura Medical News
- 1 year ago - Important Update on Listing Status and Strategic Direction - GlobeNewsWire
- 1 year ago - Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision - GlobeNewsWire
- 1 year ago - Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth - GlobeNewsWire
- 1 year ago - Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs - GlobeNewsWire
- 1 year ago - Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs. - GlobeNewsWire
- 1 year ago - Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference - GlobeNewsWire
- 1 year ago - Nemaura Medical Provides Update on Nasdaq Compliance Status and Process - GlobeNewsWire